Amdocs (DOX Quick QuoteDOX - Free Report) reported $1.19 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 3.8%. EPS of $1.98 for the same period compares to $1.83 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.19 billion, representing a surprise of -0.01%. The company has not delivered EPS surprise, with the consensus EPS estimate being $1.98.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Amdocs performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Geographic Revenue- North America: $733.9 million versus $783.99 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -3.7% change.
• Geographic Revenue- Rest of the World: $267.3 million versus the two-analyst average estimate of $218.31 million. The reported number represents a year-over-year change of +28.5%.
• Geographic Revenue- Europe: $192.6 million compared to the $192.17 million average estimate based on two analysts. The reported number represents a change of +7.1% year over year.

View all Key Company Metrics for Amdocs here>>>

Shares of Amdocs have returned +6.7% over the past month versus the Zacks S&P 500 composite's -2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.